Introduction of the 10-valent pneumococcal conjugate vaccine (PCV10) resulted in sharply reduced pneumonia cases in Kenya, according to a report from an international team of researchers.
In 2011, Kenya was the first African country to add PCV10 to its national childhood immunization schedule. The vaccine protects against 10 common strains of Streptococcus pneumoniae. The schedule called for a 3-dose series administered to infants at 6, 10, and 14 weeks of age, with a catch-up campaign for children younger than 5 years.
Friedrich M. Vaccine Reduces Pneumonia in Kenya. JAMA. 2019;321(23):2273. doi:10.1001/jama.2019.7978
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: